Highest-materiality recent filing
Nordson establishes $1.2B commercial paper program
Program allows unsecured notes up to $1.2B outstanding at any time.
Nordson Q2 record sales $741M (+8% YoY) and adj EPS $2.86 (+18% YoY); raises FY outlook
Net income $117M, $2.09 diluted EPS; adjusted diluted EPS $2.86 (record, +18% YoY).
Nordson shareholders elect three directors, ratify auditor, approve advisory say-on-pay
Christopher Mapes, Michael Merriman Jr., Sundaram Nagarajan elected to board until 2029; all received >42M votes for.
Nordson Q1 record sales $669M (+9% YoY); raises FY adj. EPS guidance to $11.00-$11.60
Q1 GAAP EPS $2.38 (up 44% YoY); adjusted EPS $2.37 (record, up 15%).
Nordson enters $1.2B revolving credit facility, repays $248M term loans
New $1.2B senior unsecured multicurrency revolving credit facility matures January 30, 2031.
Nordson reports record FY2025 sales of $2.8B; adj. EPS $10.24, up 5% YoY
Q4 sales $752M (+1% YoY); diluted EPS $2.69; adj. diluted EPS $3.03 (+9% YoY).
Nordson adopts Executive Severance Policy effective November 1, 2025
Policy provides severance benefits for US-based executive officers on qualifying termination outside change-in-control period.
Nordson Q3 sales $742M (+12%), adjusted EPS $2.73 (+13%); board adds $500M buyback
Q3 sales $742M, up 12% YoY; organic sales up 2%; acquisition impact 8%.
Nordson appoints Joseph M. Rutledge as VP and Chief Accounting Officer
Joseph M. Rutledge appointed VP and Chief Accounting Officer effective July 14, 2025.
Nordson separation agreement for departing segment leader Lovass: $832,759 cash, continued vesting
Stephen Lovass ceased as Medical and Fluid Solutions segment leader; assists transition until June 1, 2025, then separates.
Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M
Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.
Stephen Lovass ceased as MFS segment leader effective April 28, 2025; will assist transition until June 1, 2025.
Elected Annette K. Clayton (one-year term) and DeFord, Parmentier, Richey (three-year terms) with >46M votes each.
Nordson Q1 sales down 2.8% to $615M; adjusted EPS $2.06, backlog up 15%
Q1 GAAP EPS $1.65 vs $1.90 prior year; adjusted EPS $2.06 (down 7% YoY).
Q4 GAAP EPS $2.12 (down from $2.22 YoY); adjusted EPS $2.78 (up from $2.71 YoY).
Nordson completes $600M offering of 4.500% Notes due 2029; to repay $500M Term Loan
Issued $600M of 4.500% Notes due 2029 in underwritten public offering completed September 9, 2024.
Nordson Q3 sales $662M (+2% YoY); adj. EPS $2.41 (beat midpoint); FY revenue guidance raised
Q3 GAAP EPS $2.04 (down 8% YoY); adjusted EPS $2.41 (down 6% YoY, beat midpoint by $0.08).
Nordson completes acquisition of Atrion for $460 per share; borrows $825M
Completed acquisition of Atrion Corp. on Aug 21, 2024; stockholders received $460.00 per share in cash.
Nordson enters $500M term loan and increases revolver to fund Atrion acquisition
Delayed-draw $500M senior unsecured term loan; proceeds will partially fund previously announced Atrion acquisition.
Nordson to acquire Atrion for $460/share in cash, ~$810M enterprise value
Per-share consideration of $460 in cash; deal valued at ~$810M based on 1.76M shares outstanding.
Nordson to acquire Atrion for $460/share in cash, ~$800M enterprise value
Deal price $460/share cash; enterprise value ~$800M; 15x 2024 estimated EBITDA including expected synergies.
Nordson Q2 sales flat at $651M, EPS $2.05; cuts FY24 EPS guidance to $9.35-9.75
Q2 sales $651M (flat YoY); organic sales down 4%, acquisitions add 5%. Net income $118M ($2.05 EPS), down from $128M ($2.21 EPS). Adjusted EPS $2.34 vs $2.45.
Nordson announces blackout period May 31–June 30, 2024 due to 401(k) recordkeeper change
Blackout period for Nordson 401(k) plans runs from May 31, 2024 (4:00 PM ET) through week of June 30, 2024.
Nordson appoints Daniel Hopgood as CFO, effective May 20, 2024
Hopgood succeeds Joseph Kelley, who moved to Industrial Precision Solutions segment leader role.
Nordson elects Victor L. Richey Jr. as board chair; annual meeting votes pass all proposals
Shareholders elected Christopher L. Mapes to board through 2026; Jaehnert, Jones, Morris through 2027.
Nordson Q1 sales $633M (+4% YoY), adj EPS $2.21; narrows FY outlook to 4-7% growth
Sales $633M (+4% YoY); organic -2%, acquisition +5% from ARAG. Net income $110M ($1.90 EPS); adj EPS $2.21.
Nordson appoints Annette Clayton to board effective April 1, 2024
Annette Clayton joins Nordson board effective April 1, 2024; will serve on Audit Committee.
Nordson appoints Christopher Mapes, former Lincoln Electric CEO, to board
Christopher Mapes elected to Nordson board effective Jan 16, 2024; board now nine directors.
Nordson Q4 adj EPS $2.46, full-year record sales $2.6B; guides FY2024 sales growth 4-9%
Q4 sales $719M (+5% YoY); adj. EPS $2.46 vs $2.44; EBITDA record $227M (32% of sales).
Nordson CFO Kelley moves to segment leader; Shamrock named interim CFO; Pembroke retiring
CFO Joseph Kelley appointed EVP of Industrial Precision Solutions segment, effective Nov 1, 2023.
Nordson issues $850M in notes to repay €760M term loan
Completed public offering: $350M 5.600% Notes due 2028 and $500M 5.800% Notes due 2033.
Nordson closes acquisition of Arag for €957M, funded with new €760M term loan
Acquired Arag S.r.l. (agricultural spraying precision systems) for ~€957M cash, net of ~€30M debt repayment.
Nordson Q3 sales down 2% to $649M; adjusted EPS $2.35; FY23 guidance narrowed
Sales $649M (-2% YoY); organic sales -5% offset by acquisitions; GAAP EPS $2.22, adjusted EPS $2.35.
Mary G. Puma to resign from Nordson Board effective Nov 1, 2023
Mary G. Puma resigns from Nordson's Board effective November 1, 2023.
Nordson to acquire Arag S.r.l. for €960M enterprise value
Nordson Italia S.p.A. will buy Arag, a leader in precision control systems for ag spraying, from Capvis and others.
Nordson to acquire ARAG Group for €960M, expanding into precision agriculture
Enterprise value of €960M in all-cash transaction; ARAG expected FY2023 sales of €155M.
Nordson upsizes term loan to $300M and renews $850M revolver in new $1.15B credit facility
New $1.15B unsecured credit agreement: $300M term loan (3-yr) and $850M revolver (5-yr) with $75M swingline.
Nordson Q2 2023 adjusted EPS $2.26, down 7% YoY; narrows FY2023 adjusted EPS guidance
Sales $650M (+2% YoY); organic +1%, acquisition +3%, currency -2%.
Nordson amends credit agreement to replace LIBOR with SOFR and other benchmarks
First Amendment to Third Amended and Restated Credit Agreement dated April 17, 2023.
Nordson draws €180M term loan, repays €265M of existing debt
Borrowed €180M under delayed draw term loan facility entered Jan 23, 2023.
Nordson amends 8-K to correct Proposal 7; shareholders reject supermajority repeal
Proposal 5 (replace supermajority vote with simple majority) failed: 37.1M for, 11.9M against.
Proposals 5 and 6 to replace supermajority voting requirements failed; both received ~37M for and ~11.9M against.
Proposal 5 to replace certain supermajority voting requirements with simple majority failed: 37.1M for, 11.9M against.
Nordson Q1 fiscal 2023 sales $610M, adjusted EPS $1.95, guidance narrowed to $8.75-$9.50
Sales $610M, flat YoY; organic +1%, acquisition +3%, currency -4%.
Nordson enters $200M delayed draw term loan facility with PNC Bank; matures April 2024
Facility is unsecured, delayed draw; borrowings must occur by April 18, 2023.
Nordson Q4 EPS $2.44 +30% YoY; record FY2022 sales $2.6B; guides FY2023 EPS $8.75-$10.10
Q4 sales $684M (+14% YoY, +18% organic); net income $141M (+28%).
Nordson completes acquisition of CyberOptics for $54.00 per share in cash
Completed acquisition of CyberOptics on November 3, 2022; each share converted to $54.00 cash.
Nordson appoints Dr. Milton Morris to board of directors
Dr. Milton Morris, recently retired CEO of Neuspera Medical, elected to board effective Sept 15, 2022; will serve on Audit Committee.
Nordson reorganizes into three segments, provides historical financials
Effective August 1, 2022, Nordson reorganized reporting into Industrial Precision, Medical & Fluid, and Advanced Technology segments.
Nordson adds $500M to share repurchase program, total authorization ~$660M
Board authorized additional $500M for share repurchases, adding to $160M remaining from prior program.
the Original Form 8-K reported that, on April 28, 2025, Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation
Stephen Lovass ceased to serve as segment leader for the Medical and Fluid Solutions Segment of Nordson Corporation
appointed Daniel R. Hopgood, 52, as Executive Vice President, Chief Financial Officer of the Company, effective on his first day of employment, anticipated to be May 20, 2024
On February 14, 2024, the Board of Directors (the “Board”) of Nordson Corporation (the “Company”) appointed Annette Clayton as a Director to the class of directors whose term is scheduled to expire at the Company’s 2026 Annual Meeting of Shareholders and as a member of the Audit Committee.
Effective January 16, 2024, the Board of Directors (the “Board”) of Nordson Corporation (the “Company”) appointed Christopher L. Mapes as a Director to the class of directors whose term is scheduled to expire at the Company’s 2026 Annual Meeting of Shareholders and as a member of the Audit Committee.
Jeffrey A. Pembroke, who announced his intention to retire on October 17, 2023 effective as of the Transition Date.
Joseph P. Kelley, 51, Executive Vice President and Chief Financial Officer, has been appointed Executive Vice President and Industrial Precision Solutions segment leader effective November 1, 2023
Vice President and Corporate Controller, Stephen Shamrock, 51, will be appointed as interim Chief Financial Officer effective as of the Transition Date
Mary G. Puma, a member of the Board of Directors of Nordson Corporation (the “Company”), notified the Company of her intention to resign from the Company’s Board of Directors (the “Board”), effective November 1, 2023.
On September 15, 2022, the Board of Directors (the “Board”) of Nordson Corporation (the “Company”) elected Dr. Milton M. Morris as a Director
Arthur L. George, Jr., a member of the Board of Directors of Nordson Corporation (the “Company”), notified the Company of his intention to resign from the Company’s Board of Directors (the “Board”), effective May 27, 2022.
the Company and Gregory P. Merk, the Company’s Executive Vice President and a named executive officer, agreed that Mr. Merk would leave the Company on January 31, 2022.
Max materiality 0.85 · Median 0.62 · Most common event earnings